Here are the latest quarterly results of AARTI PHARMALABS. For more details, see the AARTI PHARMALABS financial fact sheet and AARTI PHARMALABS share price.
No. of Mths Qtr. Ending |
3
Mar-23* |
3
Jun-23* |
3
Sep-23* |
3
Dec-23* |
8-Qtr Chart Click to enlarge |
|
---|---|---|---|---|---|---|
Net Sales | Rs m | 4,851 | 4,584 | 4,398 | 4,487 | |
Other income | Rs m | 7 | 5 | 10 | 14 | |
Turnover | Rs m | 4,858 | 4,588 | 4,408 | 4,501 | |
Expenses | Rs m | 4,051 | 3,735 | 3,518 | 3,530 | |
Gross profit | Rs m | 800 | 849 | 880 | 957 | |
Depreciation | Rs m | 160 | 172 | 181 | 188 | |
Interest | Rs m | 59 | 42 | 39 | 45 | |
Profit before tax | Rs m | 588 | 640 | 669 | 738 | |
Tax | Rs m | 160 | 169 | 151 | 211 | |
Profit after tax | Rs m | 429 | 471 | 518 | 528 | |
Gross profit margin | % | 16.5 | 18.5 | 20.0 | 21.3 | |
Effective tax rate | % | 27.1 | 26.4 | 22.6 | 28.5 | |
Net profit margin | % | 8.8 | 10.3 | 11.8 | 11.8 | |
Diluted EPS | Rs | 4.7 | 5.2 | 5.7 | 5.8 | |
Diluted EPS (TTM) | Rs | NA | NA | NA | 21.5 | |
Subscriber Feature |
After opening the negative note, Indian share markets Slipped further as the session progressed and ended the day weak.